• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特阿拉伯阿西尔和塔布克地区 、 和 基因异常对 2 型糖尿病发展和进程的潜在影响。

Potential impact of , and gene abnormalities on the development and progression of type 2 diabetes mellitus in Asir and Tabuk regions of Saudi Arabia.

机构信息

Department of Basic Medical Sciences, College of Medicine, University of Bisha, Bisha 61922, Kingdom of Saudi Arabia.

Prince Fahd Bin Sultan Research Chair, Department of Medical Laboratory Technology (MLT), Faculty of Applied Medical Sciences, University of Tabuk, Tabuk 71491, Kingdom of Saudi Arabia.

出版信息

Mol Med Rep. 2022 May;25(5). doi: 10.3892/mmr.2022.12675. Epub 2022 Mar 16.

DOI:10.3892/mmr.2022.12675
PMID:35293603
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8941532/
Abstract

Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by persistent hyperglycemia and is associated with serious complications. The risk factors for T2DM include both genetic and lifestyle factors. Genome‑wide association studies have indicated the association of genetic variations with many diseases, including T2DM. Glucokinase (GCK) plays a key role in the regulation of insulin release in the pancreas and catalyzes the first step in glycolysis in the liver. Genetic alterations in the gene have been implicated in both hyperglycemia and hypoglycemia. MicroRNAs (miRNAs/miRs) are small non‑coding RNA molecules that are involved in the important physiological processes including glucose metabolism. In the present study, the association of the single nucleotide polymorphisms (SNPs) in the , and genes with susceptibility to T2DM in patients from two regions of Saudi Arabia were examined, using the tetra‑primer amplification refractory mutation system. The results showed that the AA genotype and the A allele of GCK rs1799884 were associated with T2DM [odds ratio (OR)=2.25, P=0.032 and OR=1.55, P=0.021, respectively]. Likewise, the CT genotype and T allele of rs11614913 were associated with an increased risk of T2DM (OR=2.36, P=0.0059 and OR=1.74, P=0.023, respectively). In addition, the CA genotype of rs6505162 C>A was found to be linked with T2DM (OR=2.12 and P=0.021). It was concluded in the present research study that gene variations in , and are potentially associated with an increased risk of T2DM. These results, in the future, may help in the identification and stratification of individuals susceptible to T2DM. Future longitudinal studies with larger sample sizes and in different ethnic populations are recommended to validate these findings.

摘要

2 型糖尿病(T2DM)是一种以持续性高血糖为特征的代谢紊乱疾病,与严重并发症有关。T2DM 的危险因素包括遗传因素和生活方式因素。全基因组关联研究表明,遗传变异与许多疾病有关,包括 T2DM。葡萄糖激酶(GCK)在胰腺中胰岛素释放的调节中发挥关键作用,并催化肝脏中糖酵解的第一步。基因中的 基因突变与高血糖和低血糖有关。微小 RNA(miRNAs/miRs)是参与包括葡萄糖代谢在内的重要生理过程的小非编码 RNA 分子。在本研究中,使用四引物扩增阻滞突变系统,研究了沙特阿拉伯两个地区的患者中 、 和 基因的单核苷酸多态性(SNP)与 T2DM 易感性的相关性。结果表明,GCK rs1799884 的 AA 基因型和 A 等位基因与 T2DM 相关[比值比(OR)=2.25,P=0.032 和 OR=1.55,P=0.021]。同样, rs11614913 的 CT 基因型和 T 等位基因与 T2DM 的风险增加相关[OR=2.36,P=0.0059 和 OR=1.74,P=0.023]。此外, rs6505162 C>A 的 CA 基因型与 T2DM 相关[OR=2.12,P=0.021]。本研究得出结论, 、 和 基因的变异可能与 T2DM 的发病风险增加有关。这些结果在未来可能有助于识别和分层易患 T2DM 的个体。建议进行未来的纵向研究,纳入更大的样本量和不同的种族人群,以验证这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5335/8941532/05552e687935/mmr-25-05-12675-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5335/8941532/cc8fd8511344/mmr-25-05-12675-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5335/8941532/05552e687935/mmr-25-05-12675-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5335/8941532/cc8fd8511344/mmr-25-05-12675-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5335/8941532/05552e687935/mmr-25-05-12675-g01.jpg

相似文献

1
Potential impact of , and gene abnormalities on the development and progression of type 2 diabetes mellitus in Asir and Tabuk regions of Saudi Arabia.沙特阿拉伯阿西尔和塔布克地区 、 和 基因异常对 2 型糖尿病发展和进程的潜在影响。
Mol Med Rep. 2022 May;25(5). doi: 10.3892/mmr.2022.12675. Epub 2022 Mar 16.
2
Deciphering the Variants Located in the , , and with Type-2 Diabetes Mellitus in Pakistani Population.解析巴基斯坦人群中 2 型糖尿病相关的 、 、 位置的变异。
Genes (Basel). 2021 Apr 28;12(5):664. doi: 10.3390/genes12050664.
3
Type 2 diabetes mellitus susceptibility gene TCF7L2 is strongly associated with hyperglycemia in the Saudi Arabia Population of the eastern province of Saudi Arabia.2型糖尿病易感基因TCF7L2与沙特阿拉伯东部省份沙特人群的高血糖密切相关。
Eur Rev Med Pharmacol Sci. 2015 Aug;19(16):3100-6.
4
Clinical Implications of Glyoxalase1 Gene Polymorphism and Elevated Levels of the Reactive Metabolite Methylglyoxal in the Susceptibility of Type 2 Diabetes Mellitus in the Patients from Asir and Tabuk Regions of Saudi Arabia.沙特阿拉伯阿西尔和塔布克地区患者中乙二醛酶1基因多态性及活性代谢物甲基乙二醛水平升高对2型糖尿病易感性的临床意义
J Pers Med. 2022 Apr 15;12(4):639. doi: 10.3390/jpm12040639.
5
Large scale meta-analyses of fasting plasma glucose raising variants in GCK, GCKR, MTNR1B and G6PC2 and their impacts on type 2 diabetes mellitus risk.大规模荟萃分析空腹血糖升高的变异 GCK、GCKR、MTNR1B 和 G6PC2 及其对 2 型糖尿病风险的影响。
PLoS One. 2013 Jun 28;8(6):e67665. doi: 10.1371/journal.pone.0067665. Print 2013.
6
Association of the glucokinase gene promoter polymorphism -30G > A (rs1799884) with gestational diabetes mellitus susceptibility: a case-control study and meta-analysis.葡萄糖激酶基因启动子多态性-30G>A(rs1799884)与妊娠期糖尿病易感性的关联:一项病例对照研究和荟萃分析。
Arch Gynecol Obstet. 2015 Aug;292(2):291-8. doi: 10.1007/s00404-015-3635-z. Epub 2015 Jan 30.
7
The miRNA variants MIR196A2 (rs11614913) and MIR423 (rs6505162) contribute to an increase in the risk of myocardial infarction.miRNA 变体 MIR196A2(rs11614913)和 MIR423(rs6505162)增加心肌梗死的风险。
Mol Genet Genomic Med. 2024 Jan;12(1):e2323. doi: 10.1002/mgg3.2323. Epub 2023 Nov 27.
8
Association of Genetic Polymorphisms in MicroRNAs With Type 2 Diabetes Mellitus in a Chinese Population.中国人群中 miRNA 基因多态性与 2 型糖尿病的相关性研究。
Front Endocrinol (Lausanne). 2021 Feb 8;11:587561. doi: 10.3389/fendo.2020.587561. eCollection 2020.
9
MTNR 1B (rs10830963) Gene Polymorphism, but not MTNR 1A (rs2119882), Associated with Type 2 Diabetes Mellitus Risk in Saudi Arabia.MTNR1B(rs10830963)基因多态性与沙特阿拉伯 2 型糖尿病风险相关,但 MTNR1A(rs2119882)并非如此。
Clin Lab. 2024 Jan 1;70(1). doi: 10.7754/Clin.Lab.2023.230651.
10
Association of glucokinase gene and glucokinase regulatory protein gene polymorphisms with gestational diabetes mellitus: A case-control study.葡萄糖激酶基因和葡萄糖激酶调节蛋白基因多态性与妊娠期糖尿病的相关性:一项病例对照研究。
Gene. 2022 May 25;824:146378. doi: 10.1016/j.gene.2022.146378. Epub 2022 Mar 8.

引用本文的文献

1
Short-Chain Fatty Acids (SCFAs) Modulate the Hepatic Glucose and Lipid Metabolism of via the FFAR/AMPK Signaling Pathway In Vitro.短链脂肪酸(SCFAs)通过游离脂肪酸受体(FFAR)/腺苷酸活化蛋白激酶(AMPK)信号通路在体外调节肝脏葡萄糖和脂质代谢。
Int J Mol Sci. 2025 Apr 12;26(8):3654. doi: 10.3390/ijms26083654.
2
Identification of Interactive Genetic Loci Linked to Insulin Resistance in Metabolic Syndrome-An Update.代谢综合征中与胰岛素抵抗相关的交互基因位点的鉴定——最新进展
Medicina (Kaunas). 2025 Jan 7;61(1):83. doi: 10.3390/medicina61010083.
3
The Role of Pro-Inflammatory Chemokines CCL-1, 2, 4, and 5 in the Etiopathogenesis of Type 2 Diabetes Mellitus in Subjects from the Asir Region of Saudi Arabia: Correlation with Different Degrees of Obesity.

本文引用的文献

1
Clinical Implications of , and Gene Abnormalities and Their Association with T2D.基因异常及其与 T2D 的关联的临床意义。
Curr Issues Mol Biol. 2021 Nov 2;43(3):1859-1875. doi: 10.3390/cimb43030130.
2
Deciphering the Variants Located in the , , and with Type-2 Diabetes Mellitus in Pakistani Population.解析巴基斯坦人群中 2 型糖尿病相关的 、 、 位置的变异。
Genes (Basel). 2021 Apr 28;12(5):664. doi: 10.3390/genes12050664.
3
Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment.肿瘤微环境中 microRNAs 的治疗靶向。
促炎趋化因子CCL-1、2、4和5在沙特阿拉伯阿西尔地区2型糖尿病发病机制中的作用:与不同程度肥胖的相关性
J Pers Med. 2024 Jul 11;14(7):743. doi: 10.3390/jpm14070743.
4
Differential Expression of Serum Proinflammatory Cytokine TNF-α and Genetic Determinants of TNF-α, CYP2C19*17, miR-423 Genes and Their Effect on Coronary Artery Disease Predisposition and Progression.血清促炎细胞因子TNF-α的差异表达以及TNF-α、CYP2C19*17、miR-423基因的遗传决定因素及其对冠状动脉疾病易感性和进展的影响。
Life (Basel). 2023 Oct 31;13(11):2142. doi: 10.3390/life13112142.
5
Nano-Stevia reduces the liver injury caused by streptozotocin (STZ)-induced diabetes in rats by targeting PEPCK/GCK genes, INSR pathway and apoptosis.纳米甜菊糖通过靶向磷酸烯醇式丙酮酸羧激酶/葡萄糖激酶(PEPCK/GCK)基因、胰岛素受体(INSR)通路和细胞凋亡来减轻链脲佐菌素(STZ)诱导的大鼠糖尿病所致的肝损伤。
J Diabetes Metab Disord. 2023 Aug 29;22(2):1519-1529. doi: 10.1007/s40200-023-01278-2. eCollection 2023 Dec.
6
Tyrosol-loaded Nano-niosomes Attenuate Diabetic Injury by TargetingGlucose Metabolism, Inflammation, and Glucose Transfer.没食子醇负载的纳米奈脂质体通过靶向葡萄糖代谢、炎症和葡萄糖转运来减轻糖尿病损伤。
Pharm Nanotechnol. 2024;12(4):351-364. doi: 10.2174/0122117385251271231018104311.
7
A critical review on therapeutic approaches of CRISPR-Cas9 in diabetes mellitus.关于CRISPR-Cas9在糖尿病治疗方法上的批判性综述。
Naunyn Schmiedebergs Arch Pharmacol. 2023 Dec;396(12):3459-3481. doi: 10.1007/s00210-023-02631-1. Epub 2023 Jul 31.
8
Association of miR-196a2 and miR-27a polymorphisms with gestational diabetes mellitus susceptibility in a Chinese population.miR-196a2 和 miR-27a 多态性与中国人群妊娠期糖尿病易感性的关联。
Front Endocrinol (Lausanne). 2023 Apr 4;14:1127336. doi: 10.3389/fendo.2023.1127336. eCollection 2023.
9
Genetic Determinants of Cardiovascular Disease: The Endothelial Nitric Oxide Synthase 3 (eNOS3), Krüppel-Like Factor-14 (KLF-14), Methylenetetrahydrofolate Reductase (MTHFR), MiRNAs27a and Their Association with the Predisposition and Susceptibility to Coronary Artery Disease.心血管疾病的遗传决定因素:内皮型一氧化氮合酶3(eNOS3)、类 Kruppel 样因子-14(KLF-14)、亚甲基四氢叶酸还原酶(MTHFR)、微小RNA27a及其与冠状动脉疾病易感性和易患性的关联。
Life (Basel). 2022 Nov 16;12(11):1905. doi: 10.3390/life12111905.
10
Non-coding RNAs in diabetes mellitus and diabetic cardiovascular disease.非编码 RNA 在糖尿病及其心血管并发症中的作用。
Front Endocrinol (Lausanne). 2022 Sep 6;13:961802. doi: 10.3389/fendo.2022.961802. eCollection 2022.
Int J Mol Sci. 2021 Feb 23;22(4):2210. doi: 10.3390/ijms22042210.
4
Role of Selected miRNAs as Diagnostic and Prognostic Biomarkers in Cardiovascular Diseases, Including Coronary Artery Disease, Myocardial Infarction and Atherosclerosis.特定微小RNA作为心血管疾病(包括冠状动脉疾病、心肌梗死和动脉粥样硬化)诊断和预后生物标志物的作用
J Cardiovasc Dev Dis. 2021 Feb 19;8(2):22. doi: 10.3390/jcdd8020022.
5
Glucose metabolism-related gene polymorphisms as the risk predictors of type 2 diabetes.葡萄糖代谢相关基因多态性作为2型糖尿病的风险预测指标
Diabetol Metab Syndr. 2020 Nov 4;12(1):97. doi: 10.1186/s13098-020-00604-5.
6
Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications.肥胖、胰岛素抵抗与2型糖尿病:关联及治疗意义
Diabetes Metab Syndr Obes. 2020 Oct 9;13:3611-3616. doi: 10.2147/DMSO.S275898. eCollection 2020.
7
Effects of tumour necrosis factor on cardiovascular disease and cancer: A two-sample Mendelian randomization study.肿瘤坏死因子对心血管疾病和癌症的影响:两样本孟德尔随机化研究。
EBioMedicine. 2020 Sep;59:102956. doi: 10.1016/j.ebiom.2020.102956. Epub 2020 Aug 14.
8
MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy.微小 RNA 及其对 ZEB 家族的影响:在癌症治疗中的机制方面和治疗应用。
Biomolecules. 2020 Jul 12;10(7):1040. doi: 10.3390/biom10071040.
9
Glucokinase Activators for Type 2 Diabetes: Challenges and Future Developments.用于 2 型糖尿病的葡萄糖激酶激活剂:挑战与未来发展。
Drugs. 2020 Apr;80(5):467-475. doi: 10.1007/s40265-020-01278-z.
10
miRNA polymorphisms and risk of premature coronary artery disease.miRNA 多态性与早发冠心病风险。
Hellenic J Cardiol. 2021 Jul-Aug;62(4):278-284. doi: 10.1016/j.hjc.2020.01.005. Epub 2020 Feb 21.